| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Spyglass Pharma, Inc. (SGP) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.69M | $31.61M | - | |
| Dir | 1.69M | $31.61M | - | |
| 10% | 1.62M | $30.28M | - | |
| 10% | 1.62M | $30.28M | - | |
| 10% | 1.62M | $30.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Mathers Edward T | 10% Owner | Buy | 937,500 | $16.00 | $15,000,000.00 | +18.4% | -10.6% | - | |
| Feb 9, 2026 | Walker Paul Edward47 | 10% Owner | Buy | 937,500 | $16.00 | $15,000,000.00 | +18.4% | -10.6% | - |